A Methylation-to-Expression Feature Model for Generating Accurate Prognostic Risk Scores and Identifying Disease Targets in Clear Cell Kidney Cancer

Jeffrey A. Thompson, Carmen J. Marsit. A Methylation-to-Expression Feature Model for Generating Accurate Prognostic Risk Scores and Identifying Disease Targets in Clear Cell Kidney Cancer. In Russ B. Altman, A. Keith Dunker, Lawrence Hunter, Marylyn D. Ritchie, Teri E. Klein, editors, Biocomputing 2017: Proceedings of the Pacific Symposium, Kohala Coast, Hawaii, USA, January 3-7, 2017. pages 509-520, 2017. [doi]

@inproceedings{ThompsonM17,
  title = {A Methylation-to-Expression Feature Model for Generating Accurate Prognostic Risk Scores and Identifying Disease Targets in Clear Cell Kidney Cancer},
  author = {Jeffrey A. Thompson and Carmen J. Marsit},
  year = {2017},
  url = {http://psb.stanford.edu/psb-online/proceedings/psb17/thompson.pdf},
  researchr = {https://researchr.org/publication/ThompsonM17},
  cites = {0},
  citedby = {0},
  pages = {509-520},
  booktitle = {Biocomputing 2017: Proceedings of the Pacific Symposium, Kohala Coast, Hawaii, USA, January 3-7, 2017},
  editor = {Russ B. Altman and A. Keith Dunker and Lawrence Hunter and Marylyn D. Ritchie and Teri E. Klein},
}